News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FAB Pharma, a Biopharma Company Developing Drugs to Treat Severe Bacterial Infections, Raises €2.3 Million in Series A Funding and Begins Recruitment for a Phase I Trial of Its Lead Compound


9/14/2009 10:22:52 AM

PARIS--(BUSINESS WIRE)--FAB Pharma today announced the completion of a €2.3 million round of series A funding led by CDC innovation and co-led by Bioam Gestion.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES